Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?

J Fam Pract. 2001 Nov;50(11):928.
No abstract available

Publication types

  • Review

MeSH terms

  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Coronary Disease / etiology*
  • Coronary Disease / prevention & control*
  • Drug Monitoring / methods*
  • Drug Monitoring / standards
  • Evidence-Based Medicine
  • Humans
  • Hyperlipidemias / blood
  • Hyperlipidemias / complications*
  • Hyperlipidemias / drug therapy*
  • Hypolipidemic Agents / therapeutic use*
  • Practice Guidelines as Topic
  • Primary Prevention / methods*
  • Risk Factors
  • Time Factors
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Triglycerides